How to Avoid Desk Rejection at Clinical Gastroenterology and Hepatology (2026)
Avoid desk rejection at CGH by proving immediate GI clinical utility, realistic generalizability, and a sharper clinical relevance case.
Readiness scan
Find out if this manuscript is ready to submit.
Run the Free Readiness Scan before you submit. Catch the issues editors reject on first read.
How Clinical Gastroenterology and Hepatology is likely screening the manuscript
Use this as the fast-read version of the page. The point is to surface what editors are likely checking before you get deep into the article.
Question | Quick read |
|---|---|
Editors care most about | Immediate clinical usefulness |
Fastest red flag | Submitting mechanistic GI biology without direct practice consequence |
Typical article types | Original clinical studies, Trials, Translational studies |
Best next step | Define the clinical question |
Quick answer: Avoiding desk rejection at Clinical Gastroenterology and Hepatology starts with the AGA Institute's originality criterion and structured-abstract format. Per CGH's Elsevier Guide for Authors, Original Articles cap at 6,000 words with 6 figures/tables max and a 260-word structured abstract (background and aims, methods, results, conclusion, 4-5 keywords). Research Letters cap at 1,000 words and 1 figure/table, no abstract. CGH states explicitly: "The single most important criterion for acceptance is the originality of the work." Publication priority is determined by "novelty, impact upon clinical practice, strength of the experimental design, and mechanistic insight." CGH does not publish a desk-rejection rate; published community surveys (Editage, SciRev) estimate it at 50-60%. CGH is the AGA Institute clinical-practice journal at the GI/hepatology flagship tier (IF ~12); the significance gate weights originality and clinical-practice impact over mechanism alone. Read 4 recent CGH papers in your subarea first.
Last reviewed 2026-05-18, re-grounded against the CGH Elsevier Guide for Authors primary source (sciencedirect.com/journal/clinical-gastroenterology-and-hepatology/publish/guide-for-authors).
In our pre-submission review work with Clinical Gastroenterology and Hepatology submissions
In our pre-submission review work with Clinical Gastroenterology and Hepatology submissions, the most common early failure is generic clinical relevance.
Authors often have competent clinical data and a real GI question. The problem is that the manuscript does not yet show what a practicing gastroenterologist or hepatologist should do differently after reading it. At that point, the paper can be scientifically respectable and still be underbuilt for CGH.
The live submission materials and surrounding journal posture make the screen fairly clear:
- the journal is a clinical GI and liver owner
- the package needs a concrete clinical relevance case
- design and generalizability matter because the claims are practice-facing
- mechanistic or translational interest alone does not carry the journal fit
That means the desk screen is usually asking whether the paper is ready for GI practice relevance, not just whether it is publishable science.
Evidence basis for this Clinical Gastroenterology and Hepatology desk-rejection screen
This page uses the Elsevier guide for authors, AGA/CGH journal positioning, and Manusights submission analysis. The official facts below are included only where they change the editorial screen. CGH desk risk is mostly about clinical utility, generalizability, and whether the study is actually practice-facing.
Official or Manusights signal | Desk-rejection implication |
|---|---|
Editorial leadership: verify the current Editor-in-Chief on the journal's editorial-team page | The page treats clinical GI usefulness as the core editor-facing test |
Original research word count: 6,000 words, inclusive of main text, references, and table/figure legends | The manuscript must make a clinical decision consequence without relying on unlimited explanatory space |
Abstract limit: 260 words | The practical GI take-home must appear in the abstract, not only in the discussion |
Submission portal: http://www.editorialmanager.com/cgh | Upload readiness does not solve the harder first-pass question of whether CGH is the owner journal |
Images and Videos submission fee: USD 25 | Format-specific details can trigger administrative return, but the main editorial risk remains weak practice consequence |
Manusights submission analysis | The specific rejection pattern is "competent GI data with a generic clinical relevance statement that does not change a decision" |
How Clinical Gastroenterology and Hepatology's Editorial Filter Maps to the Canonical Desk-Rejection Causes
CGH editors screen for originality, clinical relevance, and methodological rigor. Each canonical cause has a clinical-GI specific shape.
Scope mismatch. Mechanistic GI papers where clinical consequence is incidental, basic-science studies without practice-change implication, and broad-medicine studies without GI/hepatology specificity read as out of scope at CGH. The fix: confirm the manuscript is "immediately useful to gastroenterologists and hepatologists" with the originality argument explicit in title, abstract, and cover letter.
Claim overreach. Generalizability claims from single-center or narrow cohort, practice-change recommendations from underpowered analyses, and outcome claims that exceed the study design rigor trip CGH's clinical-rigor gate.
Methodology gaps. Missing CONSORT for trials, STROBE for observational, PRISMA for systematic reviews, missing pre-registration, missing inclusion/exclusion-criteria detail, missing power analysis, and missing reproducibility documentation read as methodology gaps.
Insufficient significance. A descriptive cohort report without practice-change recommendation, an incremental refinement of a known treatment pathway, or a single-site observation without broader generalizability reads as low significance for the AGA Institute readership.
Weak abstract or first figure. The weak abstract pattern at CGH lacks the structured background-and-aims/methods/results/conclusion format or buries the clinical actionability after extensive background. The structured abstract should make practice-relevance visible in the first 260 words.
Reporting checklist mechanics. CGH requires structured 260-word abstract, 4-5 keywords, 6 figures/tables max, complete reporting per study type, AGA-style citation format, and adherence to Elsevier submission requirements. Incomplete reporting on these is a checklist-mechanics desk reject.
A Clinical Gastroenterology and Hepatology readiness check maps your manuscript against all six causes before the editor does.
Common desk rejection reasons at Clinical Gastroenterology and Hepatology
Reason | How to Avoid |
|---|---|
Clinical relevance is generic or forced | State exactly what clinical decision, pathway, or practice pattern the findings change |
The study is too narrow for the size of the claim | Resize the claim or strengthen generalizability with validation or broader cohorts |
The paper is more mechanistic than clinically actionable | Make sure patient-care consequence is visible in the main evidence chain |
The GI disease area is the setting rather than the real contribution | Keep the manuscript centered on a GI clinical question |
The cover letter says "important" but the figures do not show why | Make the practice consequence visible in results, not only in framing |
The quick answer
To avoid desk rejection at Clinical Gastroenterology and Hepatology, make sure the manuscript clears four tests.
First, the paper has to answer a GI clinical question with immediate utility. The journal is not mainly rewarding interesting background significance.
Second, the generalizability case has to be believable. A single-center or narrow cohort can still work, but only if the claim is sized honestly or the design compensates.
Third, the clinical relevance statement has to be specific. It should tell the editor what clinicians should do differently, not merely what condition matters.
Fourth, the paper has to feel more clinical than mechanistic. If the real center of gravity is mechanism, a different GI owner journal may be stronger.
If any of those four elements is weak, the manuscript is vulnerable before external review begins.
What Clinical Gastroenterology and Hepatology editors are usually deciding first
The first editorial decision at Clinical Gastroenterology and Hepatology is usually a clinical utility and journal-identity decision.
Will a GI clinician care immediately?
That is the central screen.
Does the evidence support the size of the claimed practice consequence?
Over-generalized conclusions are especially exposed in clinical journals.
Is the patient population broad enough for the way the manuscript is framed?
Design and representativeness matter because clinical consequence is the main product.
Does this belong in CGH rather than Gastroenterology, Gut, or another neighboring venue?
This is often the hidden desk question.
That is why a paper can be solid and still miss here. The journal is screening for GI clinical usefulness first, not just scientific competence.
Timeline for the Clinical Gastroenterology and Hepatology first-pass decision
Stage | What the editor is deciding | What you should have ready |
|---|---|---|
Title and abstract | Is the GI clinical question and consequence obvious immediately? | A one-sentence statement of what changes in practice or decision-making |
Editorial identity screen | Is this a clinical GI paper rather than a mechanistic or narrow translational paper? | Main figures that show clinical relevance directly |
Evidence screen | Does the study design support the scope of the claim? | Honest generalizability and appropriately sized conclusions |
Send-out decision | Is this strong enough for a selective clinical GI journal? | A manuscript where the clinical relevance statement matches the data |
Three fast ways to get desk rejected
Some patterns recur.
1. The clinical relevance statement is generic
This is the classic miss. Editors do not want a statement about disease burden. They want a statement about what changes in GI practice because of your data.
2. The manuscript makes a broad claim from a narrow cohort
Single-center studies and retrospective cohorts are not automatically disqualifying, but they become vulnerable when the paper speaks as if the evidence is universally generalizable.
3. The real manuscript is mechanistic, but the framing is clinical
CGH can publish translational work, but if the patient-care consequence is still mostly implied, the paper often looks better owned elsewhere.
Desk rejection checklist before you submit to Clinical Gastroenterology and Hepatology
Check | Why editors care |
|---|---|
The clinical relevance statement says what clinicians should do differently | Generic importance language does not carry this journal |
The claim is sized to the actual cohort and design | Clinical journals scrutinize generalizability quickly |
The main figures already show patient-care consequence | Editors do not want to infer clinical importance from the discussion alone |
The GI question is central, not incidental | Journal identity matters at first pass |
A GI clinician could explain the practical take-home in one sentence | This is the cleanest screen for CGH fit |
Desk-reject risk
Run the scan while these rejection patterns are in front of you.
See which patterns your manuscript has before an editor does.
Submit If
- the study answers a specific GI clinical question with a visible practice consequence
- the evidence supports the size of the clinical claim
- the clinical relevance statement is concrete, data-linked, and not interchangeable with any GI paper
- the sample, cohort, endpoint, or validation path supports the stated generalizability
- the study looks clinically owned from page one without a long cover-letter bridge
- the owner journal is clearly CGH rather than a more mechanistic GI venue
When those conditions are true, the manuscript starts to look like a plausible Clinical Gastroenterology and Hepatology submission rather than a respectable GI study aimed slightly off target.
Think Twice If
- the clinical relevance statement could fit almost any GI paper
- the cohort is narrow but the abstract language is sweeping
- the main figure is mechanistic while the clinical claim is practice-facing
- the table of patient characteristics exposes limits the conclusion does not admit
- the clinical consequence appears mainly in the discussion instead of the abstract and results
What tends to get through versus what gets rejected
The difference is usually not whether the study is real. It is whether the manuscript behaves like a clinically useful GI paper.
Papers that get through usually do three things well:
- they make the GI practice consequence visible early
- they keep the claim aligned to the strength and breadth of the evidence
- they look clinically owned rather than mechanistically reframed
Papers that get rejected often fall into one of these patterns:
- generic clinical relevance
- narrow dataset with oversized claim
- mechanistic center of gravity hidden under clinical language
That is why CGH can feel sharper than expected. The journal is screening for practice-facing usefulness, not just publishability.
Clinical Gastroenterology and Hepatology versus nearby alternatives
This is often the real fit decision.
Clinical Gastroenterology and Hepatology works best when the study changes or clarifies GI clinical decision-making.
Gastroenterology may be better when the real contribution is mechanistic or field-shaping in a broader GI science sense.
Gut may be better when the paper has a different editorial and readership posture, especially in certain population, microbiome, or broader GI conversations.
A more focused clinical journal may be better when the study is useful but narrower in audience or consequence.
That distinction matters because many desk rejections here are journal-selection errors in disguise.
The page-one test before submission
Before submitting, ask:
Can a CGH editor tell, in under two minutes, what GI clinical problem this paper solves, what a clinician should do differently, and why the evidence is strong enough to justify that conclusion?
If the answer is no, the manuscript is vulnerable.
For this journal, page one should make four things obvious:
- the GI clinical question
- the practice consequence
- the honest generalizability of the evidence
- the reason this belongs in CGH rather than a more mechanistic venue
That is the real triage standard.
Common desk-rejection triggers
- generic clinical relevance statement
- broad claim from narrow cohort
- mechanistic paper with thin clinical consequence
- GI disease serving as setting rather than owner question
A Clinical Gastroenterology and Hepatology desk-rejection risk check can flag those first-read problems before the manuscript reaches the editor.
Practically, before submitting, read 4 recent papers in your CGH subarea (IBD, hepatology, esophageal/gastric, pancreaticobiliary, endoscopy, motility). Note where each structured abstract names the clinical question, how the methods establish generalizability, and how the conclusion translates findings into clinical action. The gap between your manuscript's clinical-actionability case and theirs is the gap a CGH editor will see.
For cross-journal comparison after the canonical page, use the how to avoid desk rejection journal hub.
Manuscript status while you wait
If you have already submitted, see Clinical Gastroenterology and Hepatology Under Review for the portal meaning, follow-up threshold, and reviewer-risk preparation window. That status page connects this guide to the live waiting period after submission.
Frequently asked questions
The most common reasons are that the manuscript does not prove immediate clinical utility for GI practice, the generalizability claim is too large for a single-center or narrow cohort, or the paper is more mechanistic than clinically actionable.
Editors usually decide whether the study is directly useful to gastroenterologists or hepatologists in practice, whether the evidence supports that clinical claim, and whether the journal owner is CGH rather than a more mechanistic GI venue.
The biggest first-read mistake is a generic clinical relevance statement that describes disease burden or study importance without saying what a GI clinician should do differently after reading the paper.
Only when the clinical consequence is immediate and clearly demonstrated. If the real center of gravity is mechanism rather than practice change, the paper often fits better at a more mechanistic journal.
Sources
- Clinical Gastroenterology and Hepatology guide for authors
- Clinical Gastroenterology and Hepatology journal page
- Clinical Gastroenterology and Hepatology submission portal
- CGH Elsevier media profile
- American Gastroenterological Association journals information
- CGH Elsevier Guide for Authors
- CGH publishes clinical research with practice-change implication; browse the current issue for 2025 representative work across IBD, hepatology, endoscopy, and motility.
Before you upload
Choose the next useful decision step first.
Move from this article into the next decision-support step. The scan works best once the journal and submission plan are clearer.
Use the scan once the manuscript and target journal are concrete enough to evaluate.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Where to go next
Same journal, next question
- Clinical Gastroenterology and Hepatology Submission Guide
- Clinical Gastroenterology and Hepatology Review Time: What Authors Can Actually Expect
- Clinical Gastroenterology and Hepatology Impact Factor 2026: 12.0, Q1, Rank 9/147
- Clinical Gastroenterology and Hepatology 'Under Review': What the Status Means
Supporting reads
Conversion step
Choose the next useful decision step first.
Use the scan once the manuscript and target journal are concrete enough to evaluate.